← FDA DRUG APPROVALS

FDA NDA · NDA018183

MYCELEX

Sponsor: BAYER HEALTHCARE LLC

APPLICATION
NDA018183
TYPE
NDA
ORIGINAL APPROVAL
1979-01-15
LATEST ACTION
2001-08-29
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

MYCELEXDiscontinued
CLOTRIMAZOLE 1% · CREAM · TOPICAL

Approval history

2001-08-29Manufacturing (CMC) · Supplement 19 · standardAP
2001-08-29Manufacturing (CMC) · Supplement 21 · standardAP
2000-09-21Manufacturing (CMC) · Supplement 20 · standardAP
1999-08-06Manufacturing (CMC) · Supplement 18 · standardAP
1999-08-06Manufacturing (CMC) · Supplement 16 · standardAP
1999-08-06Manufacturing (CMC) · Supplement 17 · standardAP
1996-08-15Manufacturing (CMC) · Supplement 15 · standardAP
1996-06-03Labeling · Supplement 14AP
1995-04-03Labeling · Supplement 13AP
1993-05-12Manufacturing (CMC) · Supplement 12 · standardAP
1993-01-29Manufacturing (CMC) · Supplement 11 · standardAP
1992-08-07Manufacturing (CMC) · Supplement 10 · standardAP
1991-04-01Labeling · Supplement 8AP
1991-03-29Labeling · Supplement 9AP
1979-01-15Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →